Delivery Order SPE2DR25D3111-SPE2DR26FF3VH
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 2, 2026, by the Defense Logistics Agency for the supply of Trulicity 0.75 mg/0.5 ml pens valued at $1,424.16. The award represents a competitive, non-set-aside contract with firm fixed pricing and is scheduled for completion by January 5, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 20, 2025, for Trulicity 0.75 mg/0.5 ml pens valued at $4,850.62. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 21, 2025, and performance will occur at the vendor's Conshohocken facility. The award represents a child contract executed under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on November 17, 2025, for Trulicity 0.75 mg/0.5 ml pen injections valued at $4,323.42. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 18, 2025, and performance will occur at the company's Conshohocken, Pennsylvania location. The delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,453.41 on December 15, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with an ultimate completion date of December 16, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and is funded by the Defense Logistics Agency (DLA), a defense agency component of the Department of Defense. The award represents...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $3,832.33 to supply Trulicity 0.75 mg/0.5 ml pens. This competitive, firm fixed-price delivery order is scheduled for completion by October 22, 2025, and represents a continuation of the company's pharmaceutical supply services supporting federal military and veteran healthcare systems. The award carries no set-aside...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $10,128.98 for Trulicity 0.75 mg/0.5 mL pens by the Defense Logistics Agency Medical Supply Chain. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and was competitively awarded without set-aside provisions. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,907.40 by the Defense Logistics Agency (DLA) on November 24, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens. This firm fixed price, non-set-aside contract is designated as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026...
- The Defense Logistics Agency awarded a $1,769.00 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on December 4, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider,...
- AmerisourceBergen Drug Corp was awarded a $1,067.17 delivery order on November 20, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 0.75 mg/0.5 mL pen injections. This firm fixed-price contract is non-competitive with no set-aside designation and carries an ultimate completion date of November 21, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3111Indefinite Delivery Contract
- SPE2DR25D3111-SPE2DR26FF3VHDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,424.13 delivery order by the Defense Logistics Agency on January 6, 2026, for Trulicity 0.75 mg/0.5 mL pen (0.5 mL) with a completion date of January 7, 2026. This firm fixed-price contract represents a non-competitive set-aside award and will be performed at the vendor's Conshohocken, Pennsylvania location. The award is issued as a child contract under AmerisourceBergen's parent company, Cencora, Inc., which operates under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2031. This prime IDC serves as the comprehensive vehicle enabling the supply of pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order for Trulicity, a prescription diabetes medication, exemplifies the routine pharmaceutical procurement conducted through DLA's medical supply chain to support Defense Health Agency and military treatment facility requirements. AmerisourceBergen's role as a key pharmaceutical prime vendor demonstrates its continued capability to fulfill federal medical supply needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. The firm fixed-price structure and small-dollar value are consistent with the company's typical delivery order activity under its DLA master contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/5/26 |